The Effect of Sirolimus Plus Maraviroc on the Expression of Chemokine Receptor 5 (CCR5) and the HIV-1 Viral Reservoir in HIV-Infected Renal Transplant Recipients
Latest Information Update: 05 Nov 2021
At a glance
- Drugs Maraviroc (Primary) ; Sirolimus (Primary)
- Indications HIV-1 infections; Renal transplant rejection
- Focus Proof of concept; Therapeutic Use
- 17 Jul 2019 Status changed from recruiting to withdrawn prior to enrolment.
- 17 Jul 2019 Planned End Date changed from 1 Jul 2020 to 17 Jul 2019.
- 17 Jul 2019 Planned primary completion date changed from 1 Jan 2020 to 17 Jul 2019.